Wells Fargo lowered the firm’s price target on Ryan Specialty (RYAN) to $56 from $63 and keeps an Overweight rating on the shares. The firm notes the company reported adjusted EPS of 45c, missing its/consensus estimate of 49c. The downside reflects lower organic revenue, lower acquired revenue, and lower adjusted EBITDAC margin.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $43 from $58 at Piper Sandler
- Ryan Specialty price target lowered to $52 from $58 at Barclays
- Ryan Specialty price target lowered to $55 from $65 at Keefe Bruyette
- Ryan Specialty Launches Empower Program and Share Repurchases
- Ryan Specialty sees FY26 organic revenue growth in the high-single digits